Ane Appelt
@cancerphysicist.bsky.social
Physicist, cancer & radiotherapy researcher, trialist, data nerd. Global low-carbon / train traveller. Occasional caver & underground photographer. Professor of Clinical Medical Physics at Rigshospitalet & DTU, Copenhagen, DK #radonc #medphys
AAPM, here I come! Only my 2nd time ever, and 7 years since I last went 😳 Have acquired a few more grey hair & wrinkles in the meantime, but still excited to hear what’s happening on the other side of the pond. And please all reach out if you want to meet up! #medphys #AAPM2025
July 25, 2025 at 3:07 PM
Biked the 7km home in the rain in high heels and a dress. I believe this means I’m now formally reassimilated? 🇩🇰 🚴♀️
#Copenhagen #CyclingCulture
#Copenhagen #CyclingCulture
July 11, 2025 at 7:00 PM
Biked the 7km home in the rain in high heels and a dress. I believe this means I’m now formally reassimilated? 🇩🇰 🚴♀️
#Copenhagen #CyclingCulture
#Copenhagen #CyclingCulture
My inaugural lecture as Professor of Clinical Medical Physics at Rigshospitalet and DTU will be on the 6th Oct at 3pm in Auditorium 1, Rigshospitalet, Copenhagen
It would be lovely to see a lot of familiar faces, for the lecture and for the reception afterwards ☺️
#medphys #radonc
It would be lovely to see a lot of familiar faces, for the lecture and for the reception afterwards ☺️
#medphys #radonc
July 2, 2025 at 8:04 AM
Survived the first week in my new workplace. Got an office, computer, keys & ID card - and so many lovely and welcoming colleagues. Key items have been added to my empty office shelves, and I’ve got tentative plans for stuff to work on over the coming months. Could do with some sleep, though 😂
June 20, 2025 at 4:16 PM
Survived the first week in my new workplace. Got an office, computer, keys & ID card - and so many lovely and welcoming colleagues. Key items have been added to my empty office shelves, and I’ve got tentative plans for stuff to work on over the coming months. Could do with some sleep, though 😂
Reposted by Ane Appelt
For noen kan et lite regnbueflagg bety at vi føler oss tryggere. Man ser flagget og tenker; « her kan jeg passe inn»
En enkel måte å vite at jeg også blir satt pris på.
Veldig fin video
Oslo Pride🌈
En enkel måte å vite at jeg også blir satt pris på.
Veldig fin video
Oslo Pride🌈
May 28, 2025 at 5:15 PM
For noen kan et lite regnbueflagg bety at vi føler oss tryggere. Man ser flagget og tenker; « her kan jeg passe inn»
En enkel måte å vite at jeg også blir satt pris på.
Veldig fin video
Oslo Pride🌈
En enkel måte å vite at jeg også blir satt pris på.
Veldig fin video
Oslo Pride🌈
Oh well, that didn’t quite go to plan … Got 9 hours of restful sleep and a shower, but now stuck in Cologne waiting for a replacement bus. At least I’ve got good company! #ESTRO25
May 7, 2025 at 6:59 AM
Oh well, that didn’t quite go to plan … Got 9 hours of restful sleep and a shower, but now stuck in Cologne waiting for a replacement bus. At least I’ve got good company! #ESTRO25
Interesting perspective on #ESTRO25 from a #healthecon researcher. Where is all the research on decision making, patient preferences, valuation - and, to some extend, QoL and PROMs?
I have to say I don't feel like I've gotten a lot out of #ESTRO25 overall. On the one hand, fair dos, it's a clinical conference and I'm not a clinician. But I work on preferences/decision-making/QOL/etc. and that seems really relevant to the area.
May 6, 2025 at 9:09 AM
Interesting perspective on #ESTRO25 from a #healthecon researcher. Where is all the research on decision making, patient preferences, valuation - and, to some extend, QoL and PROMs?
Love it when a plan comes together! This year’s joint #ESTRO25-AAPM symposium is the culmination of 3 years of cross-Atlantic #reirradiation collaboration🤩
🔹Chuck Mayo: #medphys-led workflows
🔹Søren Bentzen: #radbio
🔹Marija Popovic: dose accumulation
🔹Lone Hoffmann: reRT trial design & QA
🔹Chuck Mayo: #medphys-led workflows
🔹Søren Bentzen: #radbio
🔹Marija Popovic: dose accumulation
🔹Lone Hoffmann: reRT trial design & QA
May 6, 2025 at 7:37 AM
Love it when a plan comes together! This year’s joint #ESTRO25-AAPM symposium is the culmination of 3 years of cross-Atlantic #reirradiation collaboration🤩
🔹Chuck Mayo: #medphys-led workflows
🔹Søren Bentzen: #radbio
🔹Marija Popovic: dose accumulation
🔹Lone Hoffmann: reRT trial design & QA
🔹Chuck Mayo: #medphys-led workflows
🔹Søren Bentzen: #radbio
🔹Marija Popovic: dose accumulation
🔹Lone Hoffmann: reRT trial design & QA
Dose metrics linked to bowel toxicity for rectal RT in the RAPIDO trial: Amazing work by Max Tanaka from NKI
Medium-to-high dose volumes for bowel bag (RTOG or Embrace) best predictors for both acute & late toxicity - V30Gy for LCRT, V20Gy for short course #ESTRO25 #radonc #medphys
Medium-to-high dose volumes for bowel bag (RTOG or Embrace) best predictors for both acute & late toxicity - V30Gy for LCRT, V20Gy for short course #ESTRO25 #radonc #medphys
May 5, 2025 at 3:59 PM
Inter-centre variation in image registration for #reirradiation from DK: Two great studies from collaborators presented at #ESTRO25
Conclusions: Image registration-based dose accum for reRT is feasible. For lung, DIR is better than RIR. Radiobio factors largest source of variation #radonc #medphys
Conclusions: Image registration-based dose accum for reRT is feasible. For lung, DIR is better than RIR. Radiobio factors largest source of variation #radonc #medphys
May 5, 2025 at 3:41 PM
Inter-centre variation in image registration for #reirradiation from DK: Two great studies from collaborators presented at #ESTRO25
Conclusions: Image registration-based dose accum for reRT is feasible. For lung, DIR is better than RIR. Radiobio factors largest source of variation #radonc #medphys
Conclusions: Image registration-based dose accum for reRT is feasible. For lung, DIR is better than RIR. Radiobio factors largest source of variation #radonc #medphys
Great to see first outputs from ESTRO-EORTC ReCare cohort on high-dose #reirradiation - such data are sorely needed! Jonas Willmann presented characteristics for first 290 patients #ESTRO25; w/ large groups of thoracic & pelvic cancers. Current patient enrolment closing in on 500 patients! #radonc
May 5, 2025 at 8:40 AM
Great to see first outputs from ESTRO-EORTC ReCare cohort on high-dose #reirradiation - such data are sorely needed! Jonas Willmann presented characteristics for first 290 patients #ESTRO25; w/ large groups of thoracic & pelvic cancers. Current patient enrolment closing in on 500 patients! #radonc
May 5, 2025 at 7:04 AM
Amazing Reirradiation Meet&Greet session at #ESTRO25 today! Fantastic turnout, and great opportunity to present how much we’ve already done on #reirradiation within ESTRO
Now really looking forward to working with all the new members of the Reirradiation Focus group #radonc #medphys
Now really looking forward to working with all the new members of the Reirradiation Focus group #radonc #medphys
May 4, 2025 at 2:21 PM
Amazing Reirradiation Meet&Greet session at #ESTRO25 today! Fantastic turnout, and great opportunity to present how much we’ve already done on #reirradiation within ESTRO
Now really looking forward to working with all the new members of the Reirradiation Focus group #radonc #medphys
Now really looking forward to working with all the new members of the Reirradiation Focus group #radonc #medphys
Slightly delayed, but a summary of the key reirradiation sessions and presentation at today's #ESTRO25
In particular, note the dedicated #RTT and #brachytherapy reirradiation sessions 😍
#radonc #medphys #reirradiation
In particular, note the dedicated #RTT and #brachytherapy reirradiation sessions 😍
#radonc #medphys #reirradiation
May 4, 2025 at 10:05 AM
Slightly delayed, but a summary of the key reirradiation sessions and presentation at today's #ESTRO25
In particular, note the dedicated #RTT and #brachytherapy reirradiation sessions 😍
#radonc #medphys #reirradiation
In particular, note the dedicated #RTT and #brachytherapy reirradiation sessions 😍
#radonc #medphys #reirradiation
I’m SO delighted to finally see first STAR-TREC data reported 🤩 #ESTRO25
Short course RT vs chemorad for organ preservation in early stage rectal cancer
61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer
Short course RT vs chemorad for organ preservation in early stage rectal cancer
61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer
May 4, 2025 at 10:02 AM
I’m SO delighted to finally see first STAR-TREC data reported 🤩 #ESTRO25
Short course RT vs chemorad for organ preservation in early stage rectal cancer
61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer
Short course RT vs chemorad for organ preservation in early stage rectal cancer
61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer
PLATO ACT 4 results for dose de-escalation in early-stage anal cancer are out! Prof Sebag-Montefiore presents on the plenary stage at #ESTRO24
3-year locoregional failure 16.4% for standard dose IMRT vs 12.4% reduced dose IMRT
Primary endpoint is met! Reduced dose IMRT is safe & effective
#radonc
3-year locoregional failure 16.4% for standard dose IMRT vs 12.4% reduced dose IMRT
Primary endpoint is met! Reduced dose IMRT is safe & effective
#radonc
May 4, 2025 at 9:50 AM
Yesterday was terrible for my coffee sampling! Far too busy meeting people, and only managed a single coffee from the GE stand. At least it was a delightful reunion with both their barista and their excellent coffee (and the queue was short!). #ESTRO25 #CoffeeChallenge
May 4, 2025 at 5:58 AM
Yesterday was terrible for my coffee sampling! Far too busy meeting people, and only managed a single coffee from the GE stand. At least it was a delightful reunion with both their barista and their excellent coffee (and the queue was short!). #ESTRO25 #CoffeeChallenge
Things that make me happy:
Seeing an RT planning & evaluation solution for #reirradiation that I’ve helped develop in its (nearly) final version. Amazing work by @raysearchlabs.bsky.social @solstina.bsky.social @crukradnetleeds.bsky.social & colleagues.
Probably highlight of #ESTRO25 so far for me 😍
Seeing an RT planning & evaluation solution for #reirradiation that I’ve helped develop in its (nearly) final version. Amazing work by @raysearchlabs.bsky.social @solstina.bsky.social @crukradnetleeds.bsky.social & colleagues.
Probably highlight of #ESTRO25 so far for me 😍
May 3, 2025 at 2:05 PM
Things that make me happy:
Seeing an RT planning & evaluation solution for #reirradiation that I’ve helped develop in its (nearly) final version. Amazing work by @raysearchlabs.bsky.social @solstina.bsky.social @crukradnetleeds.bsky.social & colleagues.
Probably highlight of #ESTRO25 so far for me 😍
Seeing an RT planning & evaluation solution for #reirradiation that I’ve helped develop in its (nearly) final version. Amazing work by @raysearchlabs.bsky.social @solstina.bsky.social @crukradnetleeds.bsky.social & colleagues.
Probably highlight of #ESTRO25 so far for me 😍
How do patients prioritise different aspects of non-operative rectal cancer treatment?
We conducted a prospective, longitudinal multicentre study alongside a clinical trial, asking rectal cancer patients undergoing definitive RT to help us understand their treatment preferences
#ESTRO25 #RadOnc
We conducted a prospective, longitudinal multicentre study alongside a clinical trial, asking rectal cancer patients undergoing definitive RT to help us understand their treatment preferences
#ESTRO25 #RadOnc
Off to my first #ESTRO 2025 session today!
Here's our poster, a DCE on preferences for non-surgical rectal cancer treatment. We found:
- patients accepted more toxicity for a greater chance of cure
- long-term side effects more important than short-term
- preferences stable pre/post-treatment
Here's our poster, a DCE on preferences for non-surgical rectal cancer treatment. We found:
- patients accepted more toxicity for a greater chance of cure
- long-term side effects more important than short-term
- preferences stable pre/post-treatment
May 3, 2025 at 12:48 PM
I’ve been far too busy with meetings 😳 So no coffees sampled yet 🫣
(I know, I know, I’m really letting the side down …)
Everybody else, please tell me what should be my first break stop in the exhibition hall???
#ESTRO25
(I know, I know, I’m really letting the side down …)
Everybody else, please tell me what should be my first break stop in the exhibition hall???
#ESTRO25
So @cancerphysicist.bsky.social whose coffee have you tried already? #ESTRO25
May 3, 2025 at 9:46 AM
I’ve been far too busy with meetings 😳 So no coffees sampled yet 🫣
(I know, I know, I’m really letting the side down …)
Everybody else, please tell me what should be my first break stop in the exhibition hall???
#ESTRO25
(I know, I know, I’m really letting the side down …)
Everybody else, please tell me what should be my first break stop in the exhibition hall???
#ESTRO25
Here are some of the (many) other presentations on #reirradiation today at #ESTRO25 🤩
#radonc #medphys
#radonc #medphys
May 3, 2025 at 7:54 AM
Here are some of the (many) other presentations on #reirradiation today at #ESTRO25 🤩
#radonc #medphys
#radonc #medphys